- Home
- WNEB vs CRVO Comparison
WNEB vs CRVO Comparison
Compare WNEB & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNEB
- CRVO
- Stock Information
- Founded
- WNEB 1853
- CRVO 2001
- Country
- WNEB United States
- CRVO United States
- Employees
- WNEB N/A
- CRVO N/A
- Industry
- WNEB Savings Institutions
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- WNEB Finance
- CRVO Health Care
- Exchange
- WNEB Nasdaq
- CRVO Nasdaq
- Market Cap
- WNEB 195.7M
- CRVO 67.4M
- IPO Year
- WNEB N/A
- CRVO N/A
- Fundamental
- Price
- WNEB $12.50
- CRVO $8.10
- Analyst Decision
- WNEB Buy
- CRVO Strong Buy
- Analyst Count
- WNEB 2
- CRVO 6
- Target Price
- WNEB $11.00
- CRVO $19.17
- AVG Volume (30 Days)
- WNEB 61.3K
- CRVO 110.9K
- Earning Date
- WNEB 10-22-2025
- CRVO 11-11-2025
- Dividend Yield
- WNEB 2.31%
- CRVO N/A
- EPS Growth
- WNEB N/A
- CRVO N/A
- EPS
- WNEB 0.59
- CRVO N/A
- Revenue
- WNEB $76,036,000.00
- CRVO $7,776,968.00
- Revenue This Year
- WNEB N/A
- CRVO N/A
- Revenue Next Year
- WNEB $7.36
- CRVO N/A
- P/E Ratio
- WNEB $20.56
- CRVO N/A
- Revenue Growth
- WNEB 2.15
- CRVO N/A
- 52 Week Low
- WNEB $7.63
- CRVO $1.80
- 52 Week High
- WNEB $12.70
- CRVO $19.50
- Technical
- Relative Strength Index (RSI)
- WNEB 64.26
- CRVO 38.08
- Support Level
- WNEB $11.90
- CRVO $7.76
- Resistance Level
- WNEB $12.70
- CRVO $10.48
- Average True Range (ATR)
- WNEB 0.23
- CRVO 0.65
- MACD
- WNEB -0.07
- CRVO -0.28
- Stochastic Oscillator
- WNEB 75.00
- CRVO 10.86
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.